The cannabinoid CB1 receptor is expressed in pancreatic δ-cells

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Luc F. Van Gaal, Aila Rissanen, André Scheen et al. · The Lancet · 2005 · 1.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

Daniela Cota, Giovanni Marsicano, Matthias H. Tschöp et al. · Journal of Clinical Investigation · 2003 · 1.1K citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Douglas Osei‐Hyiaman, Michael A. DePetrillo, Pál Pacher et al. · Journal of Clinical Investigation · 2005 · 985 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Douglas Osei‐Hyiaman, Michael A. DePetrillo, Pál Pacher et al. · Journal of Clinical Investigation · 2005 · 920 citations

Life Sciences, Biochemistry, Pharmacology +17

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

André Scheen, Nick Finer, Priscilla Hollander et al. · The Lancet · 2006 · 736 citations · Full text

Medicine, Endocrinology, Pharmacology +13